François Bertucci
Centre National de la Recherche Scientifique
ORCID: 0000-0002-0157-0959Also affiliated with Inserm, Aix-Marseille Université, Institut Pprime, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 11 papers. Top paper: “Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study”.
Antoîne Italiano, Emannuelle Bompas, María Rios, Nicolas Penel, Olivier Mir +18 more
Sebastian K.S. Begg, Pascal Finetti, Charles R. Vanderburg, Anupriya S. Kulkarni, Azfar Neyaz +12 more
Pascal Finetti, David J. Birnbaum, François Bertucci, Keith D. Lillemoe, Andrew L. Warshaw +3 more
Gaurav B. Chauhan, Ramakrishna Edupuganti, Takahiro Kogawa, Jihyun Park, Moises Tacam +20 more
Christophe Ginestier, Flora Iovino, Carole Tarpin, Mark E. Diebel, Benjamin Esterni +13 more
Christophe Ginestier, Flora Iovino, Carole Tarpin, Mark E. Diebel, Benjamin Esterni +13 more
Steven Van Laere, Seayoung Lee, Michael A. Morse, Joseph Geradts, Luc Dirix +5 more
Pritha Pai, Seayoung Lee, Matthew W. Foster, Dorababu S. Sannareddy, François Bertucci +3 more
Yating Cheng, Yohei Funakoshi, François Bertucci, Pascal Finetti, Steven Van Laere +13 more
Aurélie Bergon, Pierre Cauchy, Brigitte Kahn‐Perlès, François Bertucci, Daniel Birnbaum +3 more
Christophe Van Berckelaer, Steven Van Laere, Alexandra Bennion, Theresa Charity, Jin‐Ming Yang +8 more